Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTSO Cytosorbents Corporation

休市中 07-11 16:00:00 EDT

1.06

-0.08

-7.02%

盘后1.06

+0.000.00%

17:50 EDT

最高1.16	最低1.05	成交量4.64万
今开1.12	昨收1.14	日振幅9.57%
总市值6,637万	流通市值5,757万	总股本6,261万
成交额5.05万	换手率0.09%	流通股本5,432万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTSO","market":"US","secType":"STK","nameCN":"Cytosorbents Corporation","latestPrice":1.06,"timestamp":1752264000000,"preClose":1.14,"halted":0,"volume":46360,"hourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.06,"latestTime":"17:50 EDT","volume":3,"amount":3.16,"timestamp":1752270621834},"delay":0,"floatShares":54315346,"shares":62610376,"eps":-0.287607,"marketStatus":"休市中","change":-0.08,"latestTime":"07-11 16:00:00 EDT","open":1.12,"high":1.1591,"low":1.05,"amount":50482.757712,"amplitude":0.095702,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.287607,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.14,"postHourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.06,"latestTime":"17:50 EDT","volume":3,"amount":3.16,"timestamp":1752270621834},"volumeRatio":0.4223953349490059,"impliedVol":2.0391,"impliedVolPercentile":0.992},"requestUrl":"/m/hq/s/CTSO","defaultTab":"news","newsList":[{"id":"2550686699","title":"Cytosorbents Corporation盘中异动 股价大跌7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550686699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550686699?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:33","pubTimestamp":1752251637,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日00时33分，Cytosorbents Corporation股票出现波动，股价快速下挫7.02%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为1.55%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712003358953eff27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712003358953eff27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2550653376","title":"Cytosorbents Corporation盘中异动 早盘急速拉升5.24%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550653376?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:40","pubTimestamp":1752068417,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时40分，Cytosorbents Corporation股票出现波动，股价急速上涨5.24%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214018a69f8fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214018a69f8fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2549553915","title":"Cytosorbents Corporation盘中异动 早盘急速上涨6.33%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549553915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549553915?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:33","pubTimestamp":1751895190,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时33分，Cytosorbents Corporation股票出现波动，股价大幅上涨6.33%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.31%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213310a69b1a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213310a69b1a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2548386413","title":"Cytosorbents Corporation盘中异动 临近午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548386413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548386413?lang=zh_cn&edition=full","pubTime":"2025-07-03 23:39","pubTimestamp":1751557177,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日23时39分，Cytosorbents Corporation股票出现波动，股价大幅拉升5.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.08%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032339389798c7b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032339389798c7b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2548489017","title":"Cytosorbents Corporation股价重挫13.95% 市值跌969.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548489017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548489017?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:31","pubTimestamp":1751463073,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时31分，Cytosorbents Corporation股票出现异动，股价大幅下跌13.95%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.08%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702213113a4cb52f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702213113a4cb52f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2547709061","title":"Cytosorbents Corporation盘中异动 早盘快速拉升5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547709061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547709061?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:31","pubTimestamp":1751290267,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分，Cytosorbents Corporation股票出现异动，股价快速上涨5.69%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.18%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213107a4c6c3e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213107a4c6c3e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2546246982","title":"Cytosorbents Corporation盘中异动 急速跳水5.83%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546246982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546246982?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:41","pubTimestamp":1750858902,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时41分，Cytosorbents Corporation股票出现异动，股价急速下挫5.83%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142978e8345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142978e8345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2545448204","title":"Cytosorbents Corporation盘中异动 快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545448204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545448204?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:42","pubTimestamp":1750689721,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时42分，Cytosorbents Corporation股票出现异动，股价快速上涨5.08%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.13%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224201978b679c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224201978b679c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2544604365","title":"Cytosorbents Corporation盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544604365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544604365?lang=zh_cn&edition=full","pubTime":"2025-06-17 00:07","pubTimestamp":1750090046,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日00时07分，Cytosorbents Corporation股票出现异动，股价快速拉升5.05%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.55%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617000726a4ac7381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617000726a4ac7381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2542532275","title":"Cytosorbents Corporation盘中异动 股价大涨5.66%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542532275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542532275?lang=zh_cn&edition=full","pubTime":"2025-06-12 03:45","pubTimestamp":1749671137,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日03时45分，Cytosorbents Corporation股票出现波动，股价急速上涨5.66%。截至发稿，该股报1.12美元/股，成交量3.9612万股，换手率0.06%，振幅6.60%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.39%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612034538a70410e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612034538a70410e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2542488773","title":"Cytosorbents Corporation盘中异动 早盘大幅跳水5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542488773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542488773?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:03","pubTimestamp":1749564215,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时03分，Cytosorbents Corporation股票出现波动，股价快速下跌5.56%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220335a7024195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220335a7024195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2541509394","title":"Cytosorbents Corporation盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541509394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541509394?lang=zh_cn&edition=full","pubTime":"2025-06-05 01:52","pubTimestamp":1749059524,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日01时52分，Cytosorbents Corporation股票出现波动，股价快速拉升5.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.34%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605015204a6fa9380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605015204a6fa9380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2540702647","title":"Cytosorbents Corporation盘中异动 大幅拉升7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540702647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540702647?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:28","pubTimestamp":1748960897,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时28分，Cytosorbents Corporation股票出现波动，股价急速上涨7.23%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.54%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603222817950d0f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603222817950d0f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2540795449","title":"Cytosorbents Corporation盘中异动 股价大涨5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540795449?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:36","pubTimestamp":1748871387,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时36分，Cytosorbents Corporation股票出现异动，股价快速拉升5.95%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.90%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213628a6f724f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213628a6f724f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2539397276","title":"Cytosorbents Corporation盘中异动 大幅拉升5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539397276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539397276?lang=zh_cn&edition=full","pubTime":"2025-05-30 23:24","pubTimestamp":1748618640,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日23时24分，Cytosorbents Corporation股票出现波动，股价快速上涨5.94%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.03%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053023240195086877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053023240195086877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2538676274","title":"Cytosorbents Corporation盘中异动 早盘快速上涨6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538676274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538676274?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:15","pubTimestamp":1748355357,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时15分，Cytosorbents Corporation股票出现波动，股价大幅拉升6.50%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为1.20%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722155795046db1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722155795046db1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2537234399","title":"Cytosorbents Corporation盘中异动 大幅跳水5.75%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537234399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537234399?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:04","pubTimestamp":1747929875,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日00时04分，Cytosorbents Corporation股票出现波动，股价大幅跳水5.75%。截至发稿，该股报0.820美元/股，成交量6.8918万股，换手率0.11%，振幅3.91%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.89%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052300043694ff5ba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052300043694ff5ba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2537193643","title":"Cytosorbents Corporation盘中异动 早盘快速拉升6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537193643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537193643?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:42","pubTimestamp":1747834975,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时42分，Cytosorbents Corporation股票出现异动，股价大幅上涨6.99%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.12%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212142559760dc9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212142559760dc9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2536163553","title":"Cytosorbents Corporation盘中异动 股价大跌6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536163553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536163553?lang=zh_cn&edition=full","pubTime":"2025-05-19 23:12","pubTimestamp":1747667560,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日23时12分，Cytosorbents Corporation股票出现异动，股价快速下跌6.67%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.12%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519231240a48437f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519231240a48437f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2535826949","title":"Cytosorbents Corporation盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535826949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535826949?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:30","pubTimestamp":1747315837,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时30分，Cytosorbents Corporation股票出现波动，股价急速拉升5.19%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，Sera Prognostics, Inc.、思泰瑞医疗、Cytosorbents Corporation涨幅较大，Autonomix Medical, Inc.、Nanovibronix, Inc.、Invo Fertility, Inc.较为活跃，换手率分别为102.95%、71.94%、2.75%，振幅较大的相关个股有Pavmed Inc.、Sera Prognostics, Inc.、Volitionrx Limited，振幅分别为12.67%、8.74%、6.25%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213038a6e06cec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213038a6e06cec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytosorbents.com","stockEarnings":[{"period":"1week","weight":-0.0275},{"period":"1month","weight":-0.0275},{"period":"3month","weight":0.0905},{"period":"6month","weight":0.1304},{"period":"1year","weight":0.088},{"period":"ytd","weight":0.1648}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cytosorbents Corporation于2002年4月25日在内华达州注册成立。该公司是重症监护运用血液净化调节炎症的集中免疫治疗公司，以预防或治疗危及生命的多器官衰竭为目标。该技术是基于生物相容的，高度多孔的聚合物吸附剂的珠子，其能够提取血液和其它体液中不需要的物质。该技术是受32项美国专利的保护。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.086963},{"month":2,"riseRate":0.818182,"avgChangeRate":0.104089},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.036736},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.069534},{"month":5,"riseRate":0.363636,"avgChangeRate":0.018485},{"month":6,"riseRate":0.636364,"avgChangeRate":0.061167},{"month":7,"riseRate":0.727273,"avgChangeRate":0.087074},{"month":8,"riseRate":0.5,"avgChangeRate":-0.045951},{"month":9,"riseRate":0.4,"avgChangeRate":0.00706},{"month":10,"riseRate":0.2,"avgChangeRate":-0.063548},{"month":11,"riseRate":0.3,"avgChangeRate":-0.070743},{"month":12,"riseRate":0.2,"avgChangeRate":-0.07363}],"exchange":"NASDAQ","name":"Cytosorbents Corporation","nameEN":"Cytosorbents"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cytosorbents Corporation,CTSO,Cytosorbents Corporation股票,Cytosorbents Corporation股票老虎,Cytosorbents Corporation股票老虎国际,Cytosorbents Corporation行情,Cytosorbents Corporation股票行情,Cytosorbents Corporation股价,Cytosorbents Corporation股市,Cytosorbents Corporation股票价格,Cytosorbents Corporation股票交易,Cytosorbents Corporation股票购买,Cytosorbents Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}